HeartBeam, Inc. (BEAT) vs Scilex Holding Company (SCLX)

A side-by-side comparison of HeartBeam, Inc. and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BEAT

HeartBeam, Inc.

$34M

$0.61HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

SCLX

Scilex Holding Company

$32M

$3.81HealthcareDelayed quote: Oct 6, 2026, 2:14 PM EDT

Total return — BEAT vs SCLX

growth of $100 · dividends reinvested · last 5y

BEAT -86.1% (-32.6%/yr)SCLX -98.9% (-59.5%/yr)BEAT compounded faster over this window

Log scale — wide-divergence pair

BEAT SCLX

BEAT vs SCLX: by the numbers

•BEAT is the larger company ($34M vs $32M market cap).
•Both run net losses; BEAT's is the smaller (0.00% vs -1414.57% net margin).

Metrics side by side

Valuation

Metric	BEAT	SCLX
P/S ratio	N/A	1.02
P/B ratio	4.12	N/A

Profitability

Metric	BEAT	SCLX
Gross margin	0.00%	49.68%
Operating margin	0.00%	-903.52%
Net margin	0.00%	-1414.57%
ROE	-248.21%	N/A
ROIC	-249.58%	N/A

Growth (annualized)

Metric	BEAT	SCLX
Revenue CAGR (5Y)	N/A	3.58%
Total return CAGR (5Y)	N/A	-59.50%

Go deeper

Full BEAT analysis Full SCLX analysis Interactive comparison tool

Dig into the metrics

HeartBeam ROE Scilex ROE HeartBeam operating margin Scilex operating margin HeartBeam revenue growth Scilex revenue growth HeartBeam free cash flow Scilex free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.